Physician profile
David A Silver
NPI 1124028501
$36,600.85
in general payments reported to CMS, 2019-2025
13 companies · $12K in 2025
The $12K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2021: $1,688 · 2022: $525 · 2023: $20K · 2024: $2,549 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $3,759 · Food and Beverage: $2,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,420.00 |
| Travel and Lodging | $3,758.60 |
| Food and Beverage | $2,060.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $22,757.76 | 2019-2024 | |
| Angiodynamics, INC. | $11,998.98 | 2023-2025 | Nanoknife |
| Histosonics, INC. | $1,067.53 | 2025 | |
| Calyxo, INC. | $276.36 | 2025 | Cvac Aspiration System |
| Astrazeneca Pharmaceuticals Lp | $223.19 | 2023-2024 | Lynparza |
| Procept Biorobotics Corporation | $113.60 | 2025 | |
| Astellas Pharma US INC | $42.73 | 2019 | |
| Blue Earth Diagnostics | $33.89 | 2025 | Posluma |
| Cook Medical LLC | $23.02 | 2025 | Zenith Alpha |
| Intuitive Surgical, INC. | $21.69 | 2024 | |
| Atricure, INC. | $19.16 | 2024 | |
| C. R. Bard, INC. & Subsidiaries | $15.20 | 2022 | |
| Alydia Health | $7.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Silver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.